Search

everythinglearnresearchcommunity

for

Search:↓

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

The research linked PLCD1 gene variants to the development of trichilemmal cysts.

Cubosomes enhance antimicrobial peptide stability and effectiveness.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

The new skin patch with human matrix and antibiotic improves wound healing.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

CCC1 is crucial for pH balance in plant cells, affecting growth and stress tolerance.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

IL-1β inhibits human hair follicle growth.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

The study found that variations in hair protein genes are likely due to evolutionary deletions or duplications.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

A Chippiparai pup was successfully treated for scabies and a fungal infection using ivermectin and topical solutions.

Stopping captopril resolved the skin and hair issues, suggesting it caused them.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Cyclosporine may cause hair loss, so patients need monitoring.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

A man developed severe skin reactions after using a treatment for hair loss.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.